| Typicality: | 0.282 |
| Saliency: | 0.077 |
| to pay 150 million | 5 | purpose |
| in the second androgel trial | 2 | location |
| jury → order → abbvie | 5 |
| negative | neutral | positive |
| 0.403 | 0.581 | 0.016 |
| Raw frequency | 5 |
| Normalized frequency | 0.077 |
| Modifier score | 0.500 |
| Perplexity | 233.825 |